Sale of NVT AG to Blue Sail Medical

King & Wood Mallesons (KWM) has advised the shareholders of NVT AG (NVT) on the sale to Blue Sail Medical Co., Ltd. (Blue Sail Medical).
NVT is a privately owned Swiss company with production sites in Germany. NVT develops, manufactures and markets medical devices for interventional cardiology and cardiac surgery for minimally invasive treatment of valvular heart disease. Blue Sail Medical, a Chinese medical device company, is listed at Shenzhen Stock Exchange. 

The share purchase agreement to acquire NVT has been signed – the closing of the transaction is subject to customary closing conditions.  

The Frankfurt KWM team around partner Dr. Sandra Link acted as German and Chinese counsel to the sellers and advised the NVT together with colleagues from Beijing on German and Chinese law issues. The Swiss law firm Walder Wyss accompanied the transaction as lead counsel and global coordinator.  

Advisors NVT AG:

KWM Frankfurt: Dr. Sandra Link (partner), Dr. Tilmann Becker (counsel | AWG key contact) (both Corporate/M&A), Markus Hill (partner), Viktoria Rosbach (associate) (both Tax) 

KWM Beijing: PAN Zhenhua (partner), ZHANG Dai (associate) (both Corporate/M&A)